Business

EQS-News: U.S. Drug Control Agency Moves to Reclassify Marijuana in a Historic Shift That Would Benefit Auri Inc. and Knockout Gummies Brand

EQS-News: U.S. Drug Control Agency Moves to Reclassify Marijuana in a Historic Shift That Would Benefit Auri Inc. and Knockout Gummies Brand.

articleAuri, Inc.May 6, 20244/company/auri-inc/news/eqs-news-us-drug-control-agency-moves-to-reclassify-marijuana-in-a-historic-shift-that-would-benefit-auri-inc-and-knockout-gummies-brand
EQS-News: U.S. Drug Control Agency Moves to Reclassify Marijuana in a Historic Shift That Would Benefit Auri Inc. and Knockout Gummies Brand

About this update from Auri, Inc.

[{"type":"text","content":"\n\n\n\n\t\n\n\n\n\n\n\n\n\n\nEQS-News: Auri Inc.\n\n\n / Key word(s): Financial\n\n\n\n\n\nU.S. Drug Control Agency Moves to Reclassify Marijuana in a Historic Shift That Would Benefit Auri Inc. and Knockout Gummies Brand 06.05.2024 / 15:08 CET/CEST\n\n\n\nThe issuer is solely responsible for the content of this announcement.\n\n DALLAS, TX - (NewMediaWire) - May 06, 2024 - Auri Inc. (OTCPK: AURI) (the Company): Today, the company shares exciting legal and market developments on marijuana law in the US.The U.S. Drug Enforcement Administration will move to reclassify marijuana as a less dangerous drug, The Associated Press has learned, a historic shift to generations of American drug policy that could have wide ripple-effects across the country. Once OMB signs off, the DEA will take public comment on the plan to move marijuana from its current classification as a Schedule I drug, alongside heroin and LSD. It moves pot to Schedule III, alongside ketamine and some anabolic steroids, following a recommendation from the federal Health and Human Services Department.This will help fuel fast growth in the marijuana industry, with an estimated worth of nearly $30 billion. Easing federal regulations could reduce the tax burden that can be 70% or more for businesses, according to industry groups. It could also make it easier to research marijuana, since it’s very difficult to conduct authorized clinical studies on Schedule I substances.The agency’s move, confirmed to the AP on Tuesday, April 30th by people familiar with the matter to discuss the sensitive regulatory review, clears the last significant regulatory hurdle before the agency’s biggest policy change in over 50 years can take effect.BY ZEKE MILLER, JOSHUA GOODMAN, JIM MUSTIAN AND LINDSAY WHITEHURST / APAPRIL 30, 2024, 1:29 PM EDTSource: TIME Magazine. https://time.com/6972835/u-s-drug-control-agency-moves-to-reclassify-marijuana-in-a-historic-shift/“Auri Inc. stands to benefit from these developments and add value Knockout, its Delta 9 and CBD line of products. Our sports and entertainment line, www.TheChamp.io, is positioned to release 14 new products this season alone! By lessening restrictions and changing categories, the development cost is now drastically reduced, while the markets and territories for sales and distribution have increased,” stated Edward Vakser, CEO. The ma...

More updates from Auri, Inc.